Development and validation of a quick and sensitive UPLC-MS/MS method for measuring ensartinib in HLMs: investigation of structural alerts associated with metabolic lability and in silico toxicity

According to evaluations performed using the DEREK and WhichP450 modules, slight changes or substitutions in the piperazine ring during drug development could yield new derivatives with improved safety and metabolic stability compared to EST.